Expanding Patient Access to Investigational Drugs Single Patient Investigational New Drug and the “Right to Try”

Overview of attention for article published in JACC: Basic to Translational Science, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter: 9 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 37 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 2 users.

JACC Journals - Journals of the American College of Cardiology, 11 May 2018

Editors’ Insights: Expanding access to investigational drugs using single patient INDs and the “Right to Try?" Learn more in…

Kardiologia, 05 May 2018

With drug approval times taking an average of 8 years from entry into clinical trials to full U.S. Food and Drug Administration …

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.